Skip to main content

Advertisement

SpringerLink
Log in

Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

In 91 of 106 adult patients with acute lymphoblastic leukemia (ALL) enrolled in the treatment protocol ALL HOVON-5 between May 1988 and October 1991, the immunophenotype of the leukemia was determined and correlated with clinical characteristics at presentation. The immunological marker analysis was performed in ten laboratories, all members of the Dutch Study Group on Immunophenotyping of Leukemias and Lymphomas (SIHON). Undifferentiated blasts were found in four patients, 67 had B-lineage ALL, 18 had T-lineage ALL, and two had biphenotypic ALL. The age of T-lineage ALL patients was lower (mean 29.3) than that of B-lineage ALL patients (mean 35.5). Tumor mass, as expressed by leukocyte count, organomegaly, and LDH, was more pronounced in T-lineage ALL. Hemoglobin and platelet count was similar in all (sub)types. CD34 was expressed in 58% of the leukemias, but most frequently in the common B-ALL (70%). Thirteen percent of the leukemias expressed one or more markers not associated with their lineage. In this prospective study immunological data were not evaluable for 15 patients. On four of them data were not available because of dry tap, for six patients the typing was technically insufficient, and for four patients the results were unclassifiable; with one patient the marker analysis was not performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baccarani M, Gobbi M, Tura S (1980) Prognostic value of immunologic markers in adults with acute lymphoblastic leukaemia. N Engl J Med 302: 123

    Google Scholar 

  2. Baccarani M, Corbelli G, Amadori S, Drenthe-Schonk A, Willemze R, Meloni G, Lopez Cardozo P, Haanen C, Mandelli F, Tura S (1982) Adolescent and adult acute lymphoblastic leukaemia: prognostic features and outcome of therapy. Blood 60: 677–684

    Google Scholar 

  3. Bain BJ (1990) Leukemia diagnosis, a guide to the FAB classification. Lippincott, Philadelphia

    Google Scholar 

  4. Barnett MJ, Greaves MF, Amess JAL, Gregory WM, Rohatiner AZS, Dhaliwal HS, Slevin ML, Biruls R, Malpas JS, Lister TA (1986) Treatment of acute lymphoblastic leukaemia in adults. Br J Haematol 64: 455–468

    Google Scholar 

  5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG (1976) Proposals for the classification of the acute leukaemias (FAB cooperative group). Br J Haematol 33: 451–458

    Google Scholar 

  6. Bennett JN, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnich HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukaemia. Ann Intern Med 103: 620–629

    Google Scholar 

  7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7): a report of the French-American-British cooperative group. Ann Intern Med 103: 460–462

    Google Scholar 

  8. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 78: 325–329

    Google Scholar 

  9. Childs C, Hirsch Ginsberg C, Walters RD, Andersson BS, Reuben J, Trujilo JM, Cork A, Stass SA, Freireich EJ, Zipf TF (1989) Myeloid surface antigen positive acute lymphoblastic leukemia (My+ALL): immunophenotyping ultrastructural, cytogenetic and molecular characteristics. Leukemia 3: 777–783

    Google Scholar 

  10. Clarkson B, Ellis S, Litle C, Gee T, Arlin Z, Mertelsmann R, Andreef M, Kempin S, Koziner B, Chaganti R, Jhanwar S, McKenzie S, Cirrincione C, Gaynor J (1985) Acute lymphoblastic leukemia in adults. Semin Oncol 12: 160–179

    Google Scholar 

  11. Dongen JJM, Adriaansen HJ, Hooijkaas H (1988) Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes. Neth J Med 33: 298–314

    Google Scholar 

  12. Drexler HG, Thiel E, Ludwig W-D (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5: 637–645

    Google Scholar 

  13. Foa R, Baldini L, Cattoretti G, Foa P, Gobbi M, Lauria F, Madon E, Masera G, Miniero R, Paolucci G, Perona G, Pizzolo G, Saitta M, Gavosto F (1985) Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study. Br J Haematol 61: 251–259

    Google Scholar 

  14. Foon KA, Todd RF (1986) Immunological classification of leukaemia and lymphoma. Blood 68: 1–31

    Google Scholar 

  15. Garand R, Vannier JP, Bene MC, Faure GC, Bernard A (1989) Correlations between acute lymphoid leukemia (ALL) immunophenotype and clinical and laboratory data at presentation. A study in 350 patients. Cancer 64: 1437–1446

    Google Scholar 

  16. Gimema cooperative group (1989) GIMEMA ALL 0183: study on adult acute lymphoblastic leukaemia in Italy. Br J Haematol 71: 377–386

    Google Scholar 

  17. Greaves MF, Lister TA (1981) Prognostic importance of immunologic markers in adult lymphoblastic leukaemia. N Engl J Med 304: 119–120

    Google Scholar 

  18. Hoelzer D, Thiel E, Loffler H, Buchner T, et al. (1988) Prognostic factors in a multicenter study for the treatment of acute lymphoblastic leukaemia in adults. Blood 71: 123–131

    Google Scholar 

  19. Hooijkaas H, Hahlen K, Adriaansen J, Dekker I, Zanen GE van, Dongen JJM van (1989) Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukaemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma. Blood 74: 416–422

    Google Scholar 

  20. Liang R, Chan TK, Chan GTC, Todd D (1989) Treatment of adult acute lymphoblastic leukaemia using an intensive chemotherapy protocol. Cancer Chemother Pharmacol 23: 384–388

    Google Scholar 

  21. Linker CA, Leditt LJ, O'Donnell M, Forman SJ, Ries CA (1991) Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 78: 2814–2822

    Google Scholar 

  22. Marcus RE, Catovsky D, Johnson SA, Gregory WM, Talavera JG, Goldman JM, Galton DAG (1986) Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten-year period. Br J Cancer 53: 175–180

    Google Scholar 

  23. Mirro J, Zipf TF, Pui CH, Kitchingman G, Williams D, Melvin S, Murphy SB, Stass S (1985) Acute mixed-lineage leukemia: clinicopalhologic correlations and prognostic significance. Blood 66: 1115–1123

    Google Scholar 

  24. Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J (1990) Myeloid associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukaemia treated with intensive multiagent chemotherapy. Blood 75: 198–202

    Google Scholar 

  25. Radford JE, Burns CP, Jones MP, Gingrich RD, Kemp JD, Edwards RW, McFadden DB, Dick FR, Wen BC (1989) Adult acute lymphoblastic leukemia: Results of the Iowa HOP-L protocol. J Clin Oncol 7: 58–66

    Google Scholar 

  26. Reijden HJ van der, Wering ER van, Rijn JM van de, Melief CJM, Veer MB van't, Behrend H, Borne AEGKr von dem (1983) Immunological typing of acute lymphoblastic leukaemia. Scand J Haematol 30: 356–366

    Google Scholar 

  27. Sobol RE, Royston I, LeBien TW, Minowada J, Anderson K, Davey FR, Cuttner H, Schiffer C, Ellison RR, Bloomfield CD (1985) Adult acute lymphoblastic phenotypes defined by monoclonal antibodies. Blood 65: 730–735

    Google Scholar 

  28. Sobol RE, Mick R, Royston J, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield C (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316: 1111–1117

    Google Scholar 

  29. Thiel E, Kranz BR, Raghavachar A, Bartram CR, Loffler H, Messerer D, Ganser A, Ludwig W-D, Buchner T, Hoelzer D (1989) Prethymic phenotype and genotype of pre-T (CD7 + / ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 73: 1247–1258

    Google Scholar 

  30. Vaughan WP, Civin CI, Weisenburger DD, Karp JE, Graham ML, Sanger WG, Grierson HL, Joshi SS, Burke PJ (1988) Acute leukemia expressing the normal human haematopoietic stem cell membrane glycoprotein CD34 (My10). Leukemia 2: 661–666

    Google Scholar 

  31. Veer MB van't (1992) The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts. Ann Hematol 64: 161–165

    Google Scholar 

  32. Veer MB van't, Kluin-Nelemans JC, Schoot E van der, Putten WLJ van, Adriaansen HJ, Wering ER (1992) Quality assessment of immunological marker analysis and the immunological diagnosis of leukaemia and lymphoma: a multi-center study. Br J Haematol 80: 458–465

    Google Scholar 

  33. Wiersma SR, Ortega J, Sobel E, Weinberg KJ (1991) Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia in childhood. N Engl J Med 324: 800–808

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, P.O. Box 5201, NL-3008, AE Rotterdam, The Netherlands

    M. B. van't Veer & W. Sizoo

  2. Department of Statistics, Dr. Daniel den Hoed Cancer Center, Rotterdam

    W. L. J. van Putten

  3. Department of Hematology, University Hospital, Utrecht

    L. F. Verdonck & A. W. Dekker

  4. Department of Hematology, Free University Hospital, Amsterdam

    G. J. Ossenkoppele

  5. Department of Hematology, University Hospital Dijkzigt, Rotterdam

    B. Löwenberg

  6. Department of Hematology, University Hospital, Leiden

    J. C. Kluin-Nelemans

  7. Department of Hematology, Leyenburg Hospital, The Hague

    P. W. Wijermans

  8. Department of Hematology, University Hospital, Maastricht, The Netherlands

    H. C. Schouten

Authors
  1. M. B. van't Veer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. L. J. van Putten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. F. Verdonck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. J. Ossenkoppele
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Löwenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. C. Kluin-Nelemans
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. W. Wijermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. C. Schouten
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Sizoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. W. Dekker
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The following persons participated in the immunophenotyping studies:

E. van der Schoot, Central Laboratory Red Cross Blood Transfusion Service, Amsterdam;A. E. G. Kr. von dem Borne, Acad. Medical Center, Amsterdam; J.J.M. Hoffmann, Catharina Hospital, Eindhoven; P. Wijermans, Leyenburgh Hospital, The Hague; J. Mulder, Regional Immunologic Lab., Leeuwarden; J. C. Kluin-Nelemans, University Hospital, Leiden; D. J. van Rheenen, University Hospital Annadal, Maastricht; H. J. Adriaansen, Erasmus Univ., Rotterdam; M. B. van't Veer, Dr. Daniel den Hoed Cancer Center, Rotterdam; H. Lokhorst, University Hospital, Utrecht; The Netherlands.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van't Veer, M.B., van Putten, W.L.J., Verdonck, L.F. et al. Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation. Ann Hematol 66, 277–282 (1993). https://doi.org/10.1007/BF01695969

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695969

Key words

Search

Navigation